ADAMTS16 antisense RNA 1 (ADAMTS16-AS1)

ADAMTS16 antisense RNA 1 (ADAMTS16-AS1) is a human long noncoding antisense RNA (also referred to as a natural antisense transcript, or NAT), transcribed from the locus opposite to the ADAMTS16 gene on human chromosome 5[1]. While the specific biological functions of ADAMTS16-AS1 are not characterized in current literature, antisense RNAs broadly serve as post-transcriptional and epigenetic regulators by binding complementary mRNA targets or influencing local chromatin structure. These RNAs can participate in both *cis*- and *trans*-regulation, modulating gene expression positively or negatively through mechanisms like transcriptional interference, chromatin remodeling, or mRNA stability regulation[2]. There is no current evidence that ADAMTS16-AS1 has a direct therapeutic, receptor, or enzyme function, nor that it is the target of any approved drugs. However, the broader class of antisense RNAs is of interest in cancer research and epigenetic regulation studies, and may serve as tools or objects of study for disease mechanisms and biomarker development[2]. No specific safety concerns, therapeutic challenges, or established biomarker roles are associated with ADAMTS16-AS1 itself at this time. The entry is not incorrect; however, functional and clinical details are currently lacking in published databases and literature for ADAMTS16-AS1 specifically[1][4].

Other names

AC022424.2